Browsing by Author "Sangenito, Leandro S."
Now showing items 1-9 of 9
-
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
Branquinha, Marta H. et al. | Date Issued: 2022 -
Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase
Castilho, Vanessa V. S. et al. | Date Issued: 2018 -
HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi
Sangenito, Leandro S. et al. | Date Issued: 2016 -
In vitro effects of bis(N-[4-(hydroxyphenyl)methyl]-2-pyridinemethamine) zinc perchlorate monohydrate 4 on the physiology and interaction process of Leishmania amazonensis
Sangenito, Leandro S. et al. | Date Issued: 2021 -
Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms
Sangenito, Leandro S. et al. | Date Issued: 2012 -
Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity
Sangenito, Leandro S. et al. | Date Issued: 2016 -
Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms
Sangenito, Leandro S. et al. | Date Issued: 2018 -
The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity
Marinho, Fernanda A. et al. | Date Issued: 2017 -
The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
Branquinha, Marta H. et al. | Date Issued: 2017